Ascletis Pharma Inc.

Investors

Financials & Filing

2025

2024

2023

2022

2021

2020

2019

2018

Voluntary Announcement - Ascletis Announces Poster Presentations at AASLD Annual Meeting 2023 Including a Late-Breaking Abstract of Interim Results from Phase IIb Expansion Cohort of ASC22 for Functional Cure of CHB
2023-11-13
Next Day Disclosure Returns - Share Buyback
2023-11-10
Next Day Disclosure Returns - Share Buyback
2023-11-09
Next Day Disclosure Returns - Share Buyback
2023-11-08
Next Day Disclosure Returns - Share Buyback
2023-11-07
Next Day Disclosure Returns - Share Buyback
2023-11-06
Voluntary Announcement - Gannex Published Phase I Data of ASC42, A Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D
2023-11-06
Next Day Disclosure Returns - Share Buyback
2023-11-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
2023-11-03
Next Day Disclosure Returns - Share Buyback
2023-11-02

4

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1